Coty Tops Estimates on Prestige Brands Boost Amid Turnaround
The US cosmetics conglomerate said launches from Marc Jacobs and Burberry helped boost revenues, though its full-year guidance is below consensus.
Beauty
Analysis and advice on the fast-evolving beauty business.
What Can Luxury Learn from Beauty Influencers?
In a world where earned media often speaks louder than paid marketing, the cost of not nurturing conversation can be high.
Op-Ed | Avon's Next CEO Needs to Be a Miracle Worker
Avon's CEO Sherilyn McCoy stepped down on Thursday after the beauty company reported a second-quarter loss of $45.5 million.
Beyond Avon and Mary Kay, Why Social Selling Still Works
Thanks to the growing 'gig economy' and the rise of social media, social selling businesses are thriving.
Tracking the Rise of ‘Clean’ Beauty
Non-toxic beauty is more than a trend: It’s a health issue, a political issue — and a business opportunity. As the market shifts and consumers demand more from their products, will the establishment finally catch on? Sarah Brown reports.
News Bites | Glossier Goes Global
In today's News Bites, the community-driven beauty brand details plans to enter three international markets.
The Dawn of Designer Botox?
As Botox and dermal fillers become a more normalised part of millennial beauty regimes, injectables could be become a multi-billion dollar opportunity for established luxury players.
Where Plastic is Fantastic: The World's Cosmetic Surgery Capitals
From Tehran to Taipei and Beirut to Brazil, the $20 billion global cosmetic surgery industry is quite literally changing the way the world looks.
Is Luxury Haircare Ripe for Disruption?
Digital media and the rise of niche players have disrupted the makeup and skincare categories. Is haircare next?
Why the Beauty Industry Is Betting Big on Supplements
With a new cast of indie brands going all-out and prestige beauty’s biggest retailers going all-in, are ingestible supplements a flash in the pan or a true industry disruptor?
L'Oréal Set to Sell The Body Shop to Brazil's Natura in $1.1 Billion Deal
L'Oréal said earlier this year it was reviewing its strategy for The Body Shop, which it bought for £652 million in 2006, and that the sale of the business had attracted a wide range of bidders.
The Top 15 M&A Targets in Beauty
In a market that is more competitive than ever, strategics and private equity firms alike are looking beyond makeup to acquisitions in skincare and haircare.
Rebooting Your Mother’s Beauty Brands
The prestige beauty sector is booming with successful indies, but heritage brands are finding their footing.
THE NEWS IN BRIEF
E.l.f. Beauty Sales Lift 51%
The US cosmetics giant raised its full-year sales outlook to over $2 billion as Rhode’s global expansion continues to power its revenue growth.
Remington Owner Spectrum Makes Unsolicited Push to Buy Helen of Troy
The owner of consumer brands like George Foreman and Remington said it has made multiple offers to buy the publicly listed parent company of Olive and June, Drybar and Hydro Flask.
PAI Partners to Acquire Elemis from L’Occitane
The French private equity group announced on Wednesday that it will buy the UK skin and body care brand for an undisclosed sum.
Estée Lauder Sets 2030 Growth, Margin Targets as Turnaround Advances
At its capital markets event in Shanghai, leadership said it aims to deliver mid-single-digit organic net sales growth through fiscal 2030, and unveiled a new cost-cutting and strategic roadmap.
Nykaa Quarterly Profit Nearly Triples on Beauty Demand, Margin Gains
The Indian beauty retailer said on Wednesday its second-quarter profit nearly tripled, as improved operating efficiency and strong demand for premium beauty products boosted margins.
Report: CVS Plans to Break Up Healthcare Conglomerate
The US retailer is planning to spin off its pharmacy business in what would be one of the biggest-ever breakups in the healthcare industry, according to reports.
Novo Nordisk Hikes 2026 Outlook Again
The Ozempic maker raised its full-year outlook for the third time this year on Wednesday as its Wegovy pill beat third-quarter sales forecasts, boosting the Danish firm's bid to win back ground from US rival Eli Lilly.